About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Cardiac Structure and Function in MPS | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT07361536

Cardiac Structure and Function in MPS

The purpose of this study is to better understand how heart and blood vessel problems develop in people with Mucopolysaccharidosis (MPS). The investigators are looking at certain substances in the bod...

Lead sponsor: Children's Hospital of Orange County•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Nina Movsesyan

CONTACT

714-509-3008 Metabolic.CRC@choc.org

Sponsors

Lead Sponsor

Children's Hospital of Orange County

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Age

0 - 99 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Any Participant with a molecularly confirmed diagnosis of mucopolysaccharidosis is eligible to enroll in this study
•2. Any healthy participant without a diagnosis of mucopolysaccharidosis whose age and biological sex can be matched with an enrolled mucopolysaccharidosis participant
•3. Parental / patient informed consent

Exclusion Criteria

•2. Inability to participate in the assessments required for this study

Related studies

Longitudinal Study of Neurodegenerative Disorders

NCT03333200 · MLD, Krabbe Disease, and more

COMPLETEDPhase 1/2

RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)

NCT04571970 · Mucopolysaccharidosis Type II (MPS II)

A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)

NCT02294877 · Mucopolysaccharidosis IV Type A, Morquio A Syndrome, and more

TERMINATEDPhase 1/2

Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease

NCT04088734 · MPS IIIA, Sanfilippo Syndrome, and more

TERMINATEDPhase 1/2

Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders

NCT01372228 · Hurler Syndrome (MPS I), Hurler-Scheie Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 26, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment240

Start dateSep 2025

Last updatedJan 26, 2026

Condition

MPS I MPS IV A MPS - Mucopolysaccharidosis MPS IVA

Locations shown

Children'S Hospital of Orange County

Orange, California

University of Minnesota

Minneapolis, Minnesota

Saint Louis University

St Louis, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2026Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions